Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - pulmonary
16
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Strategies for Mitigating Acute Side Effects of Lung-Targeted Nanocarriers
Approaches and Design Techniques to Alleviate Coagulation-Related Acute Side Effects of Lung-Targeted Nanocarriers Problem: Lipid nanoparticles (LNPs) play a crucial role in drug delivery, enabling targeted drug administration to specific tissues. LNPs tailored for lung-specific delivery often incorporate cationic (positively charged) lipids. Unfortunately,...
Published: 6/26/2024
|
Inventor(s):
Jacob Brenner
,
Vladimir Muzykantov
,
Jacob Myerson
,
Oscar Marcos Contreras
,
Marco Zamora
,
Serena Omo-Lamai
Keywords(s):
Bioengineering
,
Drug Delivery
,
Gene Editing
,
Gene Therapy
,
Nanotechnology
,
Platform Technology
,
Pulmonary
Category(s):
Technology Classifications > Therapeutics
Targeted modulation of noncoding BMPR2 sequences increases protein expression for treatment of
pulmonary
arterial hypertension
Problem:
Pulmonary
arterial hypertension (PAH) is a severe lung disease characterized by elevated pulmonary arterial pressure that is estimated to affect 5,000-15,000 people in the US. Without proper treatment, the elevated pressure leads to heart failure and eventually death—median survival without treatment is around 2-3 years. Management and...
Published: 6/20/2024
|
Inventor(s):
Yoseph Barash
,
Nicholas Hand
,
Louis Ghanem
,
David Lee
Keywords(s):
Pulmonary
Category(s):
Technology Classifications > Therapeutics
Novel Nanoparticle Composition Targeting Marginated Leukocytes
Problem: Acute inflammatory diseases, including sepsis, pneumonia, and acute respiratory distress syndrome (ARDS), account for over 1.5 million hospitalizations and 300,000 deaths per year in the US. These diseases all share a common cellular player known as marginated leukocytes. Marginated leukocytes are white blood cells that accumulate in the...
Published: 1/12/2024
|
Inventor(s):
Jacob Myerson
,
Jacob Brenner
,
Vladimir Muzykantov
,
Landis Walsh
,
Priyal Patel
Keywords(s):
COVID-19
,
Drug Delivery
,
Infectious Disease
,
Inflammation
,
Nanotechnology
,
Pulmonary
Category(s):
Technology Classifications > Therapeutics
Hybrid Computer Tomography Scanning System
The invention relates to a combination hybrid computer tomography (CT) system that is particularly suited for elucidating stages in
pulmonary
diseases, notably cystic fibrosis and lung cancer. Improved visualization of lung parenchyma and the margins of lung cysts (non-invasive “virtual biopsy”) may provide sufficient detail to distinguish the types...
Published: 7/25/2024
|
Inventor(s):
Han Wen
Keywords(s):
AA3B6X
,
AA3CXX
,
CT
,
HYBRID
,
lung cancer
,
Lung Disease
,
Lung-Targeted
,
Pulmonary
,
PULMONARY
FIBROSIS
,
WBXXXX
,
XFXXXX
,
X-RAY
,
YAXXXX
Category(s):
Collaboration Sought > Collaboration
,
Application > Diagnostics
,
Application > Medical Devices
,
Application > Non-Medical Devices
,
Application > Software / Apps
Improved Acoustic Plethysmograph System for Noninvasive Measurement of
Pulmonary
Function
CDC researchers have developed a novel acoustic whole body plethysmograph (AWBP) that allows measurement of tidal volume in lab animals, independent of gas compression in the lung. This system provides particular advantages over the traditional whole body plethysmograph (WBP) when measuring model animals with increased gas compression due to increased...
Published: 7/25/2024
|
Inventor(s):
David Frazer
,
Jeffrey Reynolds
Keywords(s):
AA2XXX
,
AA5XXX
,
AAXXXX
,
AC1XXX
,
AC2XXX
,
AC3XXX
,
AC6XXX
,
Acoustic
,
ACXXXX
,
ADXXXX
,
AE1BXX
,
AE1XXX
,
AE3XXX
,
AE4XXX
,
AEXXXX
,
ANIMAL
,
Animal Model
,
ANIMAL welfare
,
ASTHMA
,
Breath
,
BREATHING
,
CDC Docket Import
,
CDC Docket Import CDC Prosecuting
,
DDXXXX
,
DEVICE
,
DEXXXX
,
DXXXXX
,
FUNCTION
,
IA3XXX
,
IA5XXX
,
ICXXXX
,
IDXXXX
,
LUNG
,
lung cancer
,
Lung Disease
,
LUNGS
,
Lung-Targeted
,
Measuring
,
NIOSH
,
NIOSH-HELD
,
Plethysmograph
,
Pulmonary
,
Pulmonary
edema
,
PULMONARY
FIBROSIS
,
research
,
RESEARCH TOOL
,
RESPIRABLE
,
Respiration
,
respiratory
,
Respiratory Diseases
,
respiratory INFECTION
,
Tool
,
VBXXXX
,
VJXXXX
,
VKXXXX
,
VLXXXX
,
VOXXXX
,
VPXXXX
,
WAXXXX
,
WBXXXX
,
WCXXXX
,
WGXXXX
,
WIXXXX
,
WMXXXX
,
XDXXXX
,
XHXXXX
,
XIXXXX
,
XJXXXX
,
YCXXXX
,
YEXXXX
,
YFXXXX
Category(s):
Collaboration Sought > Licensing
,
Application > Software / Apps
,
Application > Medical Devices
,
Application > Diagnostics
,
TherapeuticArea > Pulmonology
,
TherapeuticArea > Immunology
,
Application > Research Materials
,
ResearchProducts > Research Equipment
,
TherapeuticArea > Cardiology
,
Application > Non-Medical Devices
,
TherapeuticArea > Ophthalmology
,
Application > Vaccines
,
Application > Therapeutics
,
Application > Occupational Safety and Health
,
TherapeuticArea > Infectious Disease
,
Application > Consumer Products
,
TherapeuticArea > Dental
,
TherapeuticArea > Endocrinology
,
ResearchProducts > Computational models/software
,
TherapeuticArea > Oncology
Methods for Amelioration and Treatment of Pathogen-associated Inflammatory Response
This CDC invention provides methods for preventing or treating inflammatory response-linked, infection induced pathologies, which are mediated by endogenous substance P. Substance P is a naturally-occurring and major pro-inflammatory neuromediator or neuromodulator, and elevated levels of substance P have been implicated in numerous inflammation-associated...
Published: 7/25/2024
|
Inventor(s):
Larry Anderson
,
Deborah Moore
,
Ralph Tripp
Keywords(s):
bronchoilitis
,
CAUSED
,
CDC Docket Import
,
CDC Docket Import CDC Prosecuting
,
DB3XXX
,
DB4XXX
,
DBXXXX
,
DISEASES
,
DXXXXX
,
IB3XXX
,
Infection
,
Inflammation
,
INFLAMMATORY
,
Methods
,
nitric oxide
,
OID-NCIRD-DVD
,
P
,
Pain
,
pain control
,
Prevention
,
Pulmonary
,
RESPONSE
,
RSV
,
RSV virus
,
SUBSTANCE
,
SUBSTANCE p
,
treatment
,
treatment methods
,
vasodilation
,
VASODILATOR
,
VAXXXX
,
VBXXXX
,
VDXXXX
,
VEXXXX
,
VJXXXX
,
VKXXXX
,
VLXXXX
,
VMXXXX
,
VOXXXX
,
VPXXXX
,
WAXXXX
,
WIXXXX
,
WJXXXX
,
WKXXXX
,
WMXXXX
,
XAXXXX
,
XCXXXX
,
YBXXXX
,
YCXXXX
Category(s):
Collaboration Sought > Licensing
,
TherapeuticArea > Ophthalmology
,
TherapeuticArea > Infectious Disease
,
TherapeuticArea > Cardiology
,
TherapeuticArea > Oncology
,
Application > Consumer Products
,
Application > Therapeutics
,
TherapeuticArea > Dental
,
TherapeuticArea > Endocrinology
,
Application > Vaccines
,
ResearchProducts > Antibodies
,
TherapeuticArea > Immunology
,
TherapeuticArea > Neurology
,
Application > Research Materials
,
Application > Diagnostics
,
TherapeuticArea > Geriatrics
Select M. tuberculosis Peptides as Mucosal Vaccines Against
Pulmonary
Tuberculosis
This CDC-developed technology relates to novel vaccines or boosters directed against
pulmonary
tuberculosis. There is currently only a single vaccine against tuberculosis, the (Bacillus Calmette-Guérin) BCG vaccine. Reports suggest widely variable effectiveness for the BCG vaccine and that BCG administration has very limited success against prevention...
Published: 7/25/2024
|
Inventor(s):
Bonnie Plikaytis
,
Thomas Shinnick
,
Rama Amara
,
Mani Cheruvu
,
Suraj Sable
Keywords(s):
Alaine
,
ANTIGEN
,
CDC Docket Import
,
CDC Docket Import CDC Prosecuting
,
DA3XXX
,
DAXXXX
,
DC1XXX
,
DC4XXX
,
DCXXXX
,
DXXXXX
,
Identification
,
Mucosal
,
MYCOBACTERIUM
,
OID-NCHHSTP-DTE
,
PROLINE
,
Pulmonary
,
respiratory
,
Respiratory Diseases
,
respiratory INFECTION
,
Rich
,
TUBERCULOSIS
,
Vaccine
,
VACCINE DEVELOPMENT
,
VJXXXX
,
VPXXXX
,
WIXXXX
,
WJXXXX
,
XCXXXX
,
XEXXXX
,
XHXXXX
,
YBXXXX
,
YCXXXX
Category(s):
Collaboration Sought > Licensing
,
Application > Therapeutics
,
Application > Vaccines
,
Application > Research Materials
,
TherapeuticArea > Endocrinology
,
TherapeuticArea > Oncology
,
Application > Diagnostics
,
TherapeuticArea > Dental
,
TherapeuticArea > Ophthalmology
,
TherapeuticArea > Cardiology
,
TherapeuticArea > Infectious Disease
,
ResearchProducts > Research Equipment
Intranasal Nebulizer with Disposable Drug Cartridge for Improved Delivery of Vaccines and Therapeutics
Intranasal delivery is a simple, inexpensive and needle-free route for administration of vaccines and therapeutics. This intranasal delivery technology, developed with Creare LLC., includes low-cost, disposable drug cartridges (DDCs) that mate with a durable hand-held device. The rechargeable-battery-powered device transmits ultrasonic energy to the...
Published: 7/25/2024
|
Inventor(s):
James Barry
,
Nabil Elkouh
,
Mark Bagley
,
Darin Knaus
,
Robert Trabka
,
Eric Friets
,
James Norris
,
Mark Papania
Keywords(s):
AB1XXX
,
AB3FXX
,
AB3GXX
,
AB3XXX
,
AB4XXX
,
Able
,
ABXXXX
,
AC1XXX
,
ACXXXX
,
AEROSOL
,
AEROSOL-GENERATING
,
AEROSOLIZATION
,
Aerosolized
,
AEROSOLS
,
AXXXXX
,
BACTERIA
,
Bacterial
,
BACTERIAL VACCINES
,
CARTRIDGE
,
CDC
,
CDC Docket Import
,
CDC Docket Import CDC Prosecuting
,
Chamber
,
COOLING
,
DB1XXX
,
DB2XXX
,
DB3XXX
,
DB4XXX
,
DB5XXX
,
DBXXXX
,
DC1XXX
,
DC2XXX
,
DC3XXX
,
DC4XXX
,
DC5BXX
,
DC5XXX
,
DC6XXX
,
DCXXXX
,
Delivery
,
DEVICE
,
Devices
,
Disposable
,
DRUG
,
Drug Delivery
,
DXXXXX
,
FUNGAL
,
HAND
,
Having
,
INSERT
,
Intranasal
,
Methods
,
NASAL
,
NEBULIZER
,
NIOSH-PRL
,
OID-NCIRD-DVD
,
PLATFORM
,
Platforms
,
Pulmonary
,
respiratory
,
Respiratory Diseases
,
respiratory INFECTION
,
System
,
SYSTEMS
,
therapeutic
,
therapeutic delivery
,
Vaccine
,
VACCINE DELIVERY
,
Vaccine Design
,
VACCINE DEVELOPMENT
,
VBXXXX
,
viral
,
viral vaccine
,
VJXXXX
,
VKXXXX
,
VLXXXX
,
VOXXXX
,
VPXXXX
,
WAXXXX
,
WFXXXX
,
WJXXXX
,
WKXXXX
,
WMXXXX
,
XDXXXX
,
YBXXXX
,
YCXXXX
,
YFXXXX
Category(s):
Collaboration Sought > Licensing
,
Application > Occupational Safety and Health
,
Application > Medical Devices
,
Application > Diagnostics
,
Application > Vaccines
,
Application > Therapeutics
,
TherapeuticArea > Dental
,
TherapeuticArea > Infectious Disease
,
TherapeuticArea > Endocrinology
,
TherapeuticArea > Cardiology
,
Application > Non-Medical Devices
,
TherapeuticArea > Ophthalmology
,
Application > Consumer Products
,
TherapeuticArea > Oncology
Human Influenza Virus Real-time RT-PCR Detection and Characterization Panel
This invention relates to methods of rapidly detecting influenza, including differentiating between type and subtype. Unlike culture and serological tests requiring 5 to 14 days for completion, CDC researchers developed a rapid, accurate assay, which is easily adapted to kit form. This assay also requires less labor input than immunoassays. These...
Published: 7/25/2024
|
Inventor(s):
Alexander Klimov
,
Nancy Cox
,
Lamorris Loftin
,
Stephen Lindstrom
Keywords(s):
Avian
,
Avian flu
,
Avian influenza
,
CDC
,
CDC Docket Import
,
CDC Docket Import CDC Prosecuting
,
DA4BXX
,
DA4XXX
,
DAXXXX
,
DDXXXX
,
Detection
,
DEVELOPED
,
DEVELOPING
,
Discriminate
,
discrimination
,
DXXXXX
,
INFLUENZA
,
PCR
,
PRIMERS
,
Probes
,
Pulmonary
,
respiratory
,
Respiratory Diseases
,
respiratory INFECTION
,
RT-PCR
,
Serotypes
,
SUBTYPES
,
Swine
,
tropical
,
Types
,
VETERINARY
,
viral
,
virus
,
Viruses
,
VLXXXX
,
VOXXXX
,
WBXXXX
,
WFXXXX
,
WMXXXX
,
XCXXXX
,
XEXXXX
,
YBXXXX
,
Zoo
,
Zoonotic
Category(s):
Collaboration Sought > Licensing
,
TherapeuticArea > Infectious Disease
,
Application > Therapeutics
,
Application > Consumer Products
,
Application > Occupational Safety and Health
,
Application > Diagnostics
,
Application > Research Materials
Defensin-Based Therapeutics for the Treatment of
Pulmonary
Disease
Investigators at the National Heart, Lung and Blood Institute have developed modified defensins that are resistant to degradation, have improved characteristics compared to unmodified defensins, and are promising candidates for
pulmonary
disease therapeutics. Defensins are small cationic peptides that defend the lung against pathogenic microorganisms...
Published: 7/25/2024
|
Inventor(s):
Joel Moss
Keywords(s):
ADP-ribose
,
ADP-ribose-arginine
,
ADP-RIBOSYLARGININE
,
ADP-ribosylation
,
AIRWAY
,
Arginines
,
ASTHMA
,
BBXXXX
,
cytotoxic
,
CYTOTOXICITY
,
DBXXXX
,
defensin
,
Defensins
,
DXXXXX
,
HNP-1
,
human neutrophil peptide 1
,
IB4XXX
,
IBXXXX
,
Inflammation
,
IXXXXX
,
neutrophil
,
Patent Category - Biotechnology
,
Pulmonary
,
PULMONARY
FIBROSIS
Category(s):
Collaboration Sought > Collaboration
,
Collaboration Sought > Licensing
,
TherapeuticArea > Infectious Disease
,
Application > Therapeutics
,
TherapeuticArea > Pulmonology
,
Application > Diagnostics
,
Application > Research Materials
1
2